Laclarée
PrivateLast Round
Seed
Jan 28, 2025
Total Funding Raised
$8.53M
Company Overview
Laclarée operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Seed round in January 2025.
Laclarée is a medical equipment manufacturing company that develops adaptive eyeglasses for presbyopia correction using proprietary fluid-filled lens technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Consumer Electronics
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Laclarée Comparables
Compare Laclarée with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Morrow Eyewear | 90% | |
| Fuller Vision | 88% | |
| IXI | 84% |
For institutional investors. Book with your work email.
Laclarée Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 28, 2025 | ||||
| Grant | Mar 13, 2024 | ||||
| Seed | Nov 15, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Laclarée Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| UI Investissement | Seed |
| High-Tech Gründerfonds | Seed |
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 14, 2025
Grew 21% QoQ from 14 to 17 employees.
- Oct 21, 2025
Franck Leclere appointed as the new Chief Executive Officer.
For institutional investors. Book with your work email.
Laclarée Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Laclarée's valuation, stock price, and market status.
Is Laclarée a public or private company?
Laclarée is a private company.
What is the current stock price of Laclarée?
Laclarée is a private company, so its shares have no public market price. Caplight tracks Laclarée's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Laclarée worth (valuation)?
Valuation information for Laclarée is not publicly available.
Can I buy Laclarée stock?
Laclarée shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Laclarée's last funding round?
Laclarée's most recent funding round was Seed on January 28, 2025.
Who are the main investors in Laclarée?
Key investors in Laclarée include European Innovation Council Fund, UI Investissement, High-Tech Gründerfonds, Bpifrance.
Will Laclarée IPO soon?
No public IPO plans have been announced for Laclarée.
How can I track Laclarée secondary market activity?
Caplight tracks bids, offers, and trades in Laclarée's shares on secondary markets.